Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 21 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10837019

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  2. US 10837003

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  3. US 10836759

    Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  4. US 10835593

    Modified anthrax toxin protective antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  5. US 10836721

    Thalidomide analogs and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  6. US 10829767

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  7. US 10830678

    Photo-controlled removal of targets in vitro and in vivo

    The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  8. US 10829769

    Chimeric antigen receptors targeting b-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  9. US 10829770

    Fusion proteins containing luciferase and a polypeptide of interest

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  10. US 10828364

    Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  11. US 10829768

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  12. US 10822608

    Oligonucleotide analogues targeting human LMNA

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  13. US 10822588

    Agents and methods to elicit anti-tumor immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  14. US 10813952

    NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  15. US 10813993

    Display platform from bacterial spore coat proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  16. US 10815487

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  17. US 10815301

    Anti-CD30 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  18. US 10815295

    Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  19. US 10815488

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  20. US 10808011

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  21. US 10808010

    Peptide inhibitors of phosphoglycerate mutase and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  22. US 10808225

    Use of PDL1 expressing cells to convert T cells into regulatory T cells

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  23. US 10799584

    Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  24. US 10799590

    Compositions containing a bitter tastant and at least one sophorolipid, and methods of reducing bitter taste attributed to a bitter tastant in an edible composition

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.